National and Kapodistrian University of Athens
Πειραματική μελέτη της επίδρασης των αντιοξειδωτικών φαρμάκων στο σύνδρομο ισχαιμίας - επαναιμάτωσης μετά από αποκλεισμό της υπονεφρικής μοίρας της κοιλιακής αορτής
Abstract
dc:descriptionOBJECTIVES: The purpose of this study was to assess the inflammatory molecules released after infrarenal aortic clamping. In addition, we sought to investigate whether the administration of N-acetyl-cysteine (NAC) and deferoxamine may protect from ischemia/reperfusion (I/R) injury.METHODS: Aortic clamping was performed in 36 swine, which were left untreated for 120 min. The animals were randomised to receive placebo (normal saline, n=12) (control group), n-acetylocysteine 150mg/kg in 30 min prior to clamping and 50mg/kg/h continuous administration during the ischemic period (2h) (NAC group, n=12) and IM deferoxamine 100mg/kg/d for 3 days prior to the experimental procedure and then continuous administration 100mg/kg BW for 30min before aortic clamping and also during the ischemia period (2h) (desferal group, n=12). Laboratory testing included biochemical testing, cytokine measurement (IL-6, IL-1b, IL-8, TNF-a), oxidative stress and oxidizing agents (PerOx, OxLDL, Thiol-Status). At the end of the experimental procedure tissue biopsies were taken (lung, heart muscle, liver, pancreas, kidney, spleen, small intestine and muscle). RESULTS: In all groups, there was a statistically significant increase of all inflammatory cytokines, as well as local and systemic oxidative stress. Administration of desferrioxamine and NAC was not found to be effective in decreasing cytokines during time progression. The I/R promotes histological lesions, that may be improved by NAC administration, whereas they may be aggravated by deferoxamin administration.CONCLUSION: Infrarenal aortic clamping promotes systemic inflammation and I/R injury. Administration of deferoxamine and NAC was not established to be effective in reducing tissue damage and postoperative complications. Further research is mandatory in order to determine the use of these antioxidant drugs in I/R syndrome.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Katseni, Konstantina
- Κατσένη, Κωνσταντίνα
Subjects
dc:subject × 6Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/36710